Analyst Research: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

105.55USD
19 Dec 2014
Price Change (% chg)

$-1.26 (-1.18%)
Prev Close
$106.81
Open
$106.35
Day's High
$107.36
Day's Low
$105.50
Volume
11,460,374
Avg. Vol
2,375,706
52-wk High
$109.49
52-wk Low
$86.09

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - JOHNSON & JOHNSON (JNJ-N) 5 Dec 2014 Thomson Reuters Stock Report 12 25.00
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates. 4 Dec 2014 Stock Traders Daily 12 20.00
JNJ: New Due Diligence Review: Forensic Earnings and Valuation 4 Dec 2014 New Constructs, LLC 9 25.00
"The Economy Matters" Report for JNJ: the economy's impact on JNJ's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 2 Dec 2014 MacroRisk Analytics/EconomicInvestor 8 25.00
Wright Investors Service Comprehensive Report for Johnson & Johnson 30 Nov 2014 Wright Reports 55 75.00
ValuEngine Rating and Forecast Report for JNJ 30 Nov 2014 ValuEngine, Inc. 11 25.00
Johnson & Johnson 29 Nov 2014 S&P Capital IQ – STARS Reports 11 127.00
JOHNSON & JOHNSON (JNJ) - REPORT FOR ACTIVE TRADERS 28 Nov 2014 Pechala's Reports 1 25.00
Value Graph: JOHNSON JOHNSON -- JNJ 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: JOHNSON & JOHNSON (JNJ) 22 Nov 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Alex Gorsky

54 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

56 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

55 2012 Group Worldwide Chairman

Paulus Stoffels

52 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

55 2012 Vice President, General Counsel
Search Stocks